Inside the quiet reinvention of the clinical judgment call
Neurovascular care remains one of the more complex and uncertain areas of modern medicine. Millions of people live with conditions such as intracranial aneurysms without symptoms, yet when an event occurs, the consequences are often catastrophic, carrying high mortality rates and a substantial risk of long-term neurological disability.
For neurospecialists, one of the most critical challenges is determining which cases can be safely monitored and which require intervention before a life-threatening event occurs.
That clinical uncertainty is the problem CARA Systems Inc. is attempting to address. The Brooklyn-based NYU spinout, led by Co-Founder and CEO Prithvinath Garigapuram, has developed a non-invasive clinical decision-support platform that integrates AI-driven medical imaging and patient-specific analytics into a unified workflow for neurovascular assessment. The company’s broader objective is to improve how complex neurovascular cases are evaluated by consolidating fragmented clinical and imaging information into a more consistent, interpretable, and patient-specific decision-making framework.
The...
Copyright of this story solely belongs to thenextweb.com. To see the full text click HERE
